Search Results

You are looking at 41 - 50 of 106 items for :

  • "Bladder cancer" x
  • All content x
Clear All
Full access

/11/14 Quality Indicators in the Management of Bladder Cancer Expiration Date: 4/11/14 CASE REPORT: A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management Expiration Date: 5/13/14 NCCN Guidelines® Insights

Full access

Jonathan L. Vandergrift

example, a 2007 systematic review that examined gemcitabine treatment for bladder cancer identified 28 phase II studies, 3 of which 4 studies are referenced and discussed in version 2.2012 of the NCCN Guidelines for Bladder Cancer (to view the most recent

Full access

Marina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, Thomas Martin, Claudia Collà Ruvolo, Luigi Nocera, Zhe Tian, Frederik C. Roos, Andreas Becker, Luis A. Kluth, Derya Tilki, Shahrokh F. Shariat, Fred Saad, Felix K.H. Chun, and Pierre I. Karakiewicz

Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer 11 recommend bone imaging in patients with UTUC in the presence of bone symptoms or in patients with laboratory indicators of bone metastases. Moreover, the NCCN recommendation regarding bone

Full access

Hamdy A. Azim, Abdul-Rahman Jazieh, and Mohammad Jahanzeb

cancers and usually secondary to hepatitis C virus (HCV). 8 In a subgroup analysis of a pivotal sorafenib study, a greater benefit of this drug was seen among patients with HCV-associated HCC. Another example is bladder cancer, which is usually of

Full access

Alison M. Lake and William W. Roberts

urinary tract . J Urol 1997 ; 157 : 1622 – 1624 . 26. Stein JP Skinner DG . The role of lymphadenectomy in high-grade invasive bladder cancer . Urol Clin North Am 2005 ; 32 : 187 – 197 .

Full access

Vivek Verma, Swati M. Surkar, Eric D. Brooks, Charles B. Simone II, and Chi Lin

associated with improved survival in glioblastoma . J Neurooncol 2017 ; 135 : 173 – 181 . 22. Haque W Verma V Butler EB Teh BS . Radical cystectomy versus chemoradiation for muscle-invasive bladder cancer: impact of treatment facility and

Full access

Sarguni Singh, Megan Eguchi, Sung-Joon Min, and Stacy Fischer

palliative care consultation remains limited for patients in SNFs. 10 We sought to understand clinical outcomes of patients with stage II–IV pancreatic, colorectal, lung, and bladder cancers who discharge to an SNF compared with patients who discharge to home

Full access

Pooja Ghatalia and Elizabeth R. Plimack

approved in the platinum-refractory second-line setting. CheckMate 275, a phase II trial, evaluated nivolumab monotherapy in 265 patients with metastatic or nonresectable platinum-resistant bladder cancer. 15 Updated results at 33.7-month follow-up were

Full access

Robert J. Morgan

healthy tissue . Future Oncol 2010 ; 6 : 1043 – 1049 . 9 Williams H Pembroke A . Sniffer dogs in the melanoma clinic? Lancet 1989 ; 1 : 734 . 10 Willis CM Church SM Guest CM . Olfactory detection of human bladder cancer by

Full access

Robert W. Carlson

, breast, non–small cell lung, pancreatic, and bladder cancers, as well as chronic myeloid leukemia, sarcomas, and melanoma. NCCN experts provided guidance on complicated issues across the continuum of cancer care, such as access to emerging treatments and